about
Evaluation of the Xpert Carba-R (Cepheid) Assay Using Contrived Bronchial Specimens from Patients with Suspicion of Ventilator-Associated Pneumonia for the Detection of Prevalent CarbapenemasesEvolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data.Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolatesSpread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutionsProspective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.Extended-spectrum-β-lactamase-producing Escherichia coli as a cause of pediatric infections: report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain.Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.Rapid Detection of OXA-48-Producing Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryAmpicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.Phylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245 Klebsiella pneumoniae clones circulating in SpainSurvey of Carbapenemase-Producing Enterobacteriaceae in Companion Dogs in Madrid, SpainAntibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli.Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain.Carbapenemase-producing enterobacteriaceae in Spain in 2012.Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates.Dissemination and clinical implications of multidrug-resistant Klebsiella pneumoniae isolates producing OXA-48 in a Spanish hospital.Production of HlyA and ClyA haemolysins among quinolone-resistant Escherichia coli isolated from clinical samples.The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3.Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method.Vancomycin-resistant Enterococcus faecium ST17 outbreak in a Neonatal Unit.The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.Risk factors associated with carbapenemase-producing Klebsiella pneumoniae fecal carriage: A case-control study in a Spanish tertiary care hospital.Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48.Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.[Molecular characterization of resistance mechanisms: methicillin resistance Staphylococcus aureus, extended spectrum β-lactamases and carbapenemases].Interhospital spread of NDM-7-producing Klebsiella pneumoniae belonging to ST437 in Spain.Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes.Concurrent interspecies and clonal dissemination of OXA-48 carbapenemase.Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.Design of clone-specific probes from genome sequences for rapid PCR-typing of outbreak pathogens.Outbreak of multidrug-resistant CTX-M-15-producing Enterobacter cloacae in a neonatal intensive care unit.Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit.CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.[Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)].
P50
Q28354047-61876037-54DA-4AB8-B83C-4495DFC5B8FFQ30370165-0FFD1649-43D3-4F5E-9DA6-21BD6887FEE1Q31117937-2B135731-062E-43AD-9CE4-AECA351A0405Q33798430-9AB8D7FB-CA99-44CC-A720-299040F923A1Q34720052-D3699861-0970-4E54-BB15-C76A611528BDQ35607803-61A01E4E-09F3-4677-9C59-B0F2210B06B6Q35666471-906C5150-5EBC-4CE1-AAAA-7708F4A5A29CQ35666523-4B300943-3BF0-45FA-9AD9-246139972A41Q35871328-02394B5B-C44F-4A23-900E-8360E842B6EBQ35878865-02EE0760-2D3D-4330-A365-AD6FA769CF00Q36086480-30646A6B-1821-4CFC-8C96-DEC8C06E3477Q36684198-EA3EA5F4-8673-43EF-9FAC-B2492C90ED03Q36729985-A0FB21D4-1FB8-4336-B745-147B345DF115Q36803926-CB4FB7C3-0283-46E0-9650-BAF026B021D6Q36971214-3D86F6FA-7867-448B-A4B1-7B967ED46F8BQ37009537-2246D8A4-733E-409A-BAA7-2E15DE908982Q37335683-874C5379-CCD5-4A9F-9218-AFA3C6B6F5E3Q37703447-E90CB46C-0E82-4F13-8241-4B15A0A5BF5FQ38843838-6B2D1460-F348-4BD3-9120-08A780B31EC0Q39282005-03217CD9-DD31-435F-BFCA-F7DBF611D487Q39484619-6182E724-3091-4873-9E4D-4B07EDA5FC5CQ39685772-8E540DE8-97A3-4172-88BD-54A219C2CEB8Q40083456-48370397-6FEF-44E3-80EB-8B65818218B2Q40352796-44BDDE6C-7CAE-40C1-A991-E86AF05D5BB2Q40551160-263FAB49-2529-4558-AF51-96748D637440Q40687135-2EA51B4E-3A68-4184-AAF3-F77063D97235Q40891458-64376ABD-8C77-4E4E-9286-D314850D2F3CQ40918846-D0313F95-E5AC-4F44-A0DF-29954BE19CD6Q41025333-096FE131-DE13-40C1-BE59-A371FB9E9628Q41224067-B502A1D3-CF72-4A22-964D-8C46A55393F3Q41299425-B87DC16D-9009-41E1-96EA-B184FF990EB4Q41537746-AA0B50B2-6249-47F4-93E5-D1D3DE716533Q42110520-C2B0614F-C927-4E8E-81B2-93058876B0DAQ42225093-9E0B822C-95EA-40EF-9CFA-BE1ECA9E6F4BQ42281672-006EE7E8-2927-4328-99CE-FAA5B42BD13FQ42945869-116BD02C-F8BE-42ED-97E4-2CFC851800C1Q43293884-A954694B-1D56-40D9-9587-0EC7CE8669C3Q43554150-2CD897A8-4FAE-4681-80F3-5E73BF3C657BQ43807763-291506E1-D54B-4F0B-B193-F8EE6C3300DBQ44085044-9B7F5DF8-6180-4357-8EE7-D56F274C49BA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jesús Oteo
@ast
Jesús Oteo
@en
Jesús Oteo
@es
Jesús Oteo
@nl
type
label
Jesús Oteo
@ast
Jesús Oteo
@en
Jesús Oteo
@es
Jesús Oteo
@nl
prefLabel
Jesús Oteo
@ast
Jesús Oteo
@en
Jesús Oteo
@es
Jesús Oteo
@nl
P106
P21
P31
P496
0000-0003-3327-8263